The APT Comparison Study
Brief description of study
The purpose of this clinical trial is to compare the benefits and tolerability of three medications that are FDA-approved and used for migraine preventive treatment - atogepant, a newer migraine preventive medication, propranolol, and topiramate, two older migraine preventive medications. This study will provide a head-to-head comparison of the relative effectiveness, tolerability, and continued use for the duration of the study of these medications.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Find a site
,
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or